Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depakote Sprinkle Capsules in Pediatric Partial Seizures
NCT00067431Phase 3Terminated
- Sponsor
- Abbott Laboratories
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of divalproex sodium in focal seizures (2 arms), sponsored by Abbott Laboratories. Primary endpoint: Change from baseline in the 4-week partial seizure rate. Started Jul 2003; status: terminated.
02
Drugs
divalproex sodium
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00067431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067431.